Miriplatin (Miripla)
Platinum agent used in TACE
Diseases for which it is used
History of changes in PMDA indication
- 2009-10-16: Initial approval for lipiodolization in hepatocellular carcinoma.
Also known as
- Brand name: Miripla
Platinum agent used in TACE